February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008
January 24, 2008 – “Unadjusted mortality…was significantly lower for drug-eluting stents than bare-metal stents ...
January 23, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023January 22, 2008 - A new stent with a nanothin surface application shows promise in opening and healing blocked ...
January 21, 2008January 22, 2008 - A new stent with a nanothin surface application known as Polyzene-F shows promise in opening ...
January 21, 2008January 14, 2008 - Drug-eluting stents in patients undergoing coronary artery revascularization procedures relieve ...
January 13, 2008January 10, 2008 - Patients who received OrbusNeich’s Genous Bio-engineered R Stent had significantly fewer major ...
January 09, 2008January 8, 2008 - Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease ...
January 07, 2008December 26, 2007 - Boston Scientific Corp. announced its TAXUS Liberte paclitaxel-eluting coronary stent system has ...
December 26, 2007December 27, 2007 - XTENT Inc. announced that it has submitted its application to the designated European Notified Body ...
December 26, 2007December 27, 2007 - Several new studies on genetics and stem cell research, along with studies that continue to ...
December 26, 2007December 17, 2007 - Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing ...
December 16, 2007December 14, 2007 - According to a guideline update published online today in the journals of the Society for ...
December 13, 2007December 13, 2007 - Devax Inc. announced that it has completed patient enrollment in the DIVERGE clinical trial ...
December 12, 2007December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain ...
December 06, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now